Finder Award
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Immix stock
Learn how to easily invest in Immix stock.
Immix is a biotechnology business based in the US. Immix shares (IMMX) are listed on the NASDAQ and all prices are listed in US Dollars. Immix employs 2 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy Immix stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – IMMX. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Finder Award
Finder Award
eToro
- Easy to use platform with $0 stock trading & no annual fees
- Social trading allows you to copy popular portfolios
- FINDER EXCLUSIVE: Guaranteed $15 bonus when you sign up and deposit $100
tastytrade
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $100 - $2,000 when you open and fund an account with $5,000 to $100,000+
Immix stock price (NASDAQ: IMMX)
Use our graph to track the performance of IMMX stocks over time.Immix shares at a glance
Information last updated 2023-03-24.
| Latest market close | $1.83 |
|---|---|
| 52-week range | $0.68 - $3.45 |
| 50-day moving average | $2.25 |
| 200-day moving average | $1.95 |
| Wall St. target price | $11.00 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-2.02 |
Buy Immix stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 6 of 6
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Is it a good time to buy Immix stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Immix price performance over time
Historical closes compared with the close of $1.83 from 2023-03-24
| 1 week (2023-03-20) | 3.39% |
|---|---|
| 1 month (2023-02-27) | -14.49% |
| 3 months (2022-12-27) | -8.50% |
| 6 months (2022-09-27) | 27.97% |
| 1 year (2022-03-25) | -14.08% |
|---|---|
| 2 years (2021-03-23) | N/A |
| 3 years (2020-03-23) | N/A |
| 5 years (2018-03-23) | N/A |
Immix financials
| Gross profit TTM | $0 |
|---|---|
| Return on assets TTM | -35.09% |
| Return on equity TTM | -515.22% |
| Profit margin | 0% |
| Book value | $1.20 |
| Market capitalisation | $29.8 million |
TTM: trailing 12 months
Immix share dividends
We're not expecting Immix to pay a dividend over the next 12 months.
You may also wish to consider:
- Science Applications International (SAIC.US) (1.43% forward annual dividend yield)
Immix overview
Immix Biopharma, Inc. , a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorporated in 2012 and is headquartered in Los Angeles, California. .
Immix in the news
Nexcella Announces New Positive NXC-201 Clinical Data Demonstrating 100% Complete Responses in AL Amyloidosis Patients + Additional Positive Multiple Myeloma Safety Data Demonstrating NXC-201 Outpatient CAR-T Treatment Potential
Nexcella, an Immix Biopharma Subsidiary, Announces New Positive NXC-201 Clinical Data Demonstrating 100% Complete Responses in AL Amyloidosis Patients + Additional Positive Multiple Myeloma Safety Data Demonstrating NXC-201 Outpatient CAR-T Treatment Potential
Immix Biopharma Confirms No Exposure to Silicon Valley Bank or Silvergate Bank
Frequently asked questions
What percentage of Immix is owned by insiders or institutions?Currently 62.464% of Immix shares are held by insiders and 3.021% by institutions. How many people work for Immix?
Latest data suggests 2 work at Immix. When does the fiscal year end for Immix?
Immix's fiscal year ends in December. Where is Immix based?
Immix's address is: 11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064 What is Immix's ISIN number?
Immix's international securities identification number is: US45258H1068
More guides on Finder
-
What happens if a brokerage firm fails?
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
-
How to buy gold
Learn about buying physical gold, plus stocks and ETFs, to learn how you can add gold exposure to your portfolio.
-
Silicon Valley Bank collapse: Which ETFs and stocks are impacted?
Several ETFs have exposure to Silicon Valley Bank, but it appears minimal.
-
How to Buy Treasury Bills
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
-
SVB collapses: What does it mean for your portfolio?
The 16th largest US bank has collapsed, but its impact on your portfolio could be limited depending on what you own.
-
How to buy Vanguard VTI Total Stock Market ETF units
Steps to investing in the Vanguard (VTI) Total Stock Market ETF.
-
How to buy Neuraxis (NRXS) stock when it goes public
Everything we know about the Neuraxis IPO, plus information on how to buy in.
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
Ask an Expert